The table below shows PTC THERAPEUTICS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$272.55M
$211.01M
$178.88M
$1.18B
$196.79M
$186.70M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$100.87M
$100.16M
$112.99M
$108.97M
$161.41M
$132.17M
PTCT annual revenue (10-K history)
PTC THERAPEUTICS, INC. reported annual revenue of $1.73B for fiscal year 2025. That is up 114.5% from $806.78M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $82.70M (FY 2016) to $1.73B. Figures come from the company's audited annual reports as filed with the SEC.
